The FDA assessed the security and performance of atidarsagene autotemcel based upon details from 37 kids who obtained atidarsagene autotemcel in two single-arm, open-label medical trials and in an expanded obtain application.[seven] Little ones who obtained therapy with atidarsagene autotemcel were being compared to untreated children (purely natur